Literature DB >> 28497376

Application of electrospun fibers for female reproductive health.

Anna K Blakney1, Yonghou Jiang1, Kim A Woodrow2.   

Abstract

Here, we present the current challenges in women's reproductive health and the current state-of-the-art treatment and prevention options for STI prevention, contraception, and treatment of infections. We discuss how the versatile platform of electrospun fibers can be applied to each challenge, and postulate at how these technologies could be improved. The void of approved electrospun fiber-based products yields the potential to apply this useful technology to a number of medical applications, many of which are relevant to women's reproductive health. Given the ability to tune drug delivery characteristics and three-dimensional geometry, there are many opportunities to pursue new product designs and routes of administration for electrospun fibers. For each application, we provide an overview of the versatility of electrospun fibers as a novel dosage form and summarize their advantages in clinical applications. We also provide a perspective on why electrospun fibers are well-suited for a variety of applications within women's reproductive health and identify areas that could greatly benefit from innovations with electrospun fiber-based approaches.

Entities:  

Keywords:  Contraception; Electrospun fibers; Female reproductive health; Infection; Prevention; STIs; Treatment

Mesh:

Year:  2017        PMID: 28497376      PMCID: PMC5658258          DOI: 10.1007/s13346-017-0386-3

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  80 in total

Review 1.  Electrospinning: applications in drug delivery and tissue engineering.

Authors:  Travis J Sill; Horst A von Recum
Journal:  Biomaterials       Date:  2008-02-20       Impact factor: 12.479

2.  Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.

Authors:  Heather Bradley; Lauri E Markowitz; Theda Gibson; Geraldine M McQuillan
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

3.  Oral contraceptives and the risk of myocardial infarction.

Authors:  B C Tanis; M A van den Bosch; J M Kemmeren; V M Cats; F M Helmerhorst; A Algra; Y van der Graaf; F R Rosendaal
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

Review 4.  Transcervical quinacrine sterilization: clinical experience.

Authors:  D C Sokal; J Zipper; T King
Journal:  Int J Gynaecol Obstet       Date:  1995-12       Impact factor: 3.561

5.  Layered superhydrophobic meshes for controlled drug release.

Authors:  Eric J Falde; Jonathan D Freedman; Victoria L M Herrera; Stefan T Yohe; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2015-07-06       Impact factor: 9.776

6.  Fabrication of a novel scaffold of clotrimazole-microemulsion-containing nanofibers using an electrospinning process for oral candidiasis applications.

Authors:  Prasopchai Tonglairoum; Tanasait Ngawhirunpat; Theerasak Rojanarata; Ruchadaporn Kaomongkolgit; Praneet Opanasopit
Journal:  Colloids Surf B Biointerfaces       Date:  2014-12-13       Impact factor: 5.268

Review 7.  Genitourinary Tract Infections.

Authors:  Odaliz Abreu Lanfranco; George J Alangaden
Journal:  Microbiol Spectr       Date:  2016-08

8.  RNA interference by nanofiber-based siRNA delivery system.

Authors:  Haoqing Cao; Xu Jiang; Chou Chai; Sing Yian Chew
Journal:  J Control Release       Date:  2010-02-06       Impact factor: 9.776

9.  Treatment of bacterial vaginosis with lactobacilli.

Authors:  A Hallén; C Jarstrand; C Påhlson
Journal:  Sex Transm Dis       Date:  1992 May-Jun       Impact factor: 2.830

10.  A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.

Authors:  Erica Schlesinger; Daniel Johengen; Ellen Luecke; Ginger Rothrock; Ian McGowan; Ariane van der Straten; Tejal Desai
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200

View more
  4 in total

1.  Drug delivery in female reproductive health.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

2.  Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.

Authors:  Kevin M Tyo; Amanda B Lasnik; Longyun Zhang; Mohamed Mahmoud; Alfred B Jenson; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  J Control Release       Date:  2020-02-05       Impact factor: 9.776

Review 3.  Medical Applications of Porous Biomaterials: Features of Porosity and Tissue-Specific Implications for Biocompatibility.

Authors:  Jamie L Hernandez; Kim A Woodrow
Journal:  Adv Healthc Mater       Date:  2022-02-19       Impact factor: 11.092

Review 4.  Application of Sol-Gels for Treatment of Gynaecological Conditions-Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery.

Authors:  Ritu Thapa; Shila Gurung; Marie-Odile Parat; Harendra S Parekh; Preeti Pandey
Journal:  Gels       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.